Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Uncommon Cures has launched multiple innovative clinical trial programs targeting unmet needs in the rare disease space. Their model combines centralized high-risk operations with decentralized low-risk/home-based solutions to reduce costs and accelerate timelines. Early data suggest cost savings of over 40% compared to traditional CRO models. They are actively running and expanding international sites and have signed contracts with both pharma companies and patient organizations. One current study focuses on improving tolerability of Palynziq treatment in PKU patients via rapid drug desensitization protocol.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Uncommon Cures.